Gaillon, France

Patrick Berna


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Patrick Berna: Innovator in Monoclonal Antibody Technology

Introduction

Patrick Berna is a notable inventor based in Gaillon, France. He has made significant contributions to the field of biomarker discovery through his innovative methods and platforms. His work focuses on enhancing the efficiency of monoclonal antibody-based biomarker discovery, which has far-reaching implications in various scientific and medical applications.

Latest Patents

Patrick Berna holds a patent for a "Monoclonal antibody based biomarker discovery and development platform." This invention discloses a method that integrates analyte collection, hybridoma screening, and nanovolume integrated mass spectrometry (NVIMS). The platform is designed to streamline the biomarker discovery process, potentially reducing the time required by 4-6 years compared to traditional methods. It enables rapid, high-throughput production, isolation, and characterization of disease-specific biomarkers alongside highly specific monoclonal antibodies. The applications of this method are diverse, including drug testing, biohazard applications, ecological applications, physiological applications, and pathology screening.

Career Highlights

Patrick Berna is affiliated with Northwestern University, where he continues to advance his research in biomarker discovery. His innovative approach has positioned him as a key figure in the field, contributing to the development of more efficient diagnostic tools and therapeutic strategies.

Collaborations

Patrick has collaborated with esteemed colleagues such as Laszlo A Takacs and Andras Guttman. These collaborations have further enriched his research and expanded the impact of his inventions in the scientific community.

Conclusion

Patrick Berna's contributions to monoclonal antibody technology and biomarker discovery exemplify the potential of innovation in transforming scientific research and medical diagnostics. His work not only enhances the efficiency of biomarker development but also opens new avenues for applications in various fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…